+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point of Care Testing Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968870
  • Report
  • July 2021
  • Region: Global
  • 194 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Point of Care Testing Market will Grow to USD 41.36 Billion by 2026, at a CAGR of 12.56%

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc
  • BIOMERIEUX SA
  • Danaher Corporation
  • Informa PLC
  • QIAGEN GmbH
The Global Point of Care Testing Market size was estimated at USD 20.33 Billion in 2020 and expected to reach USD 22.82 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 12.56% to reach USD 41.36 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Point of Care Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Point of Care Testing Market was studied across Cardio-metabolic Monitoring Kits, Cholesterol Test Strips, Fertility and Pregnancy Testing Kits, Glucose Monitoring Kits, Haematology Testing Kits, and Infectious Disease Testing Kits.
  • Based on End User, the Point of Care Testing Market was studied across Ambulatory Care, Home Care, Hospitals or Critical Care, Outpatient Healthcare, and Research Laboratories.
  • Based on Region, the Point of Care Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Point of Care Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Point of Care Testing Market, including Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics Holdings plc, Henry Schein, Inc, Informa PLC, Instrumentation Laboratory Company, Johnson and Johnson Service, Inc., Medtronic plc, Polymer Technology Systems, Inc., QIAGEN GmbH, Roche Holding AG, Siemens AG, Sienco, Inc., and WerfenLife, S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Point of Care Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Point of Care Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Point of Care Testing Market?
4. What is the competitive strategic window for opportunities in the Global Point of Care Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Point of Care Testing Market?
6. What is the market share of the leading vendors in the Global Point of Care Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Point of Care Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc
  • BIOMERIEUX SA
  • Danaher Corporation
  • Informa PLC
  • QIAGEN GmbH
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. End User Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic and infectious diseases globally
5.1.1.2. Favorable government policies for introduction of POC testing
5.1.1.3. Potential demand for enhanced patient-centric care with new advanced testing kits
5.1.2. Restraints
5.1.2.1. Relatively high cost involved in product development
5.1.3. Opportunities
5.1.3.1. Surge in research and development investment by manufacturers
5.1.3.2. Technological advancements in POC testing
5.1.4. Challenges
5.1.4.1. Strict regulatory policies for approval of POC testing kits
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Point of Care Testing Market, by Product
6.1. Introduction
6.2. Cardio-metabolic Monitoring Kits
6.3. Cholesterol Test Strips
6.4. Fertility and Pregnancy Testing Kits
6.5. Glucose Monitoring Kits
6.6. Haematology Testing Kits
6.7. Infectious Disease Testing Kits

7. Point of Care Testing Market, by End User
7.1. Introduction
7.2. Ambulatory Care
7.3. Home Care
7.4. Hospitals or Critical Care
7.5. Outpatient Healthcare
7.6. Research Laboratories

8. Americas Point of Care Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Point of Care Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Point of Care Testing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. ACON Laboratories, Inc.
12.3. Alere Inc
12.4. Ativa Medical Corporation
12.5. Becton, Dickinson, and Company
12.6. BIOMERIEUX SA
12.7. Chembio Diagnostics
12.8. Danaher Corporation
12.9. EKF Diagnostics Holdings plc
12.10. Henry Schein, Inc
12.11. Informa PLC
12.12. Instrumentation Laboratory Company
12.13. Johnson and Johnson Service, Inc.
12.14. Medtronic plc
12.15. Polymer Technology Systems, Inc.
12.16. QIAGEN GmbH
12.17. Roche Holding AG
12.18. Siemens AG
12.19. Sienco, Inc.
12.20. WerfenLife, S.A.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY AND PREGNANCY TESTING KITS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY AND PREGNANCY TESTING KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2026
FIGURE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. AMERICAS POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. ARGENTINA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. BRAZIL POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. CANADA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. MEXICO POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. INDIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. INDONESIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. JAPAN POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. MALAYSIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. SINGAPORE POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. THAILAND POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. FRANCE POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. GERMANY POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. ITALY POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. QATAR POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. RUSSIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SPAIN POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL POINT OF CARE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POINT OF CARE TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL POINT OF CARE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY AND PREGNANCY TESTING KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. AMERICAS POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. ARGENTINA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. BRAZIL POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. CANADA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. MEXICO POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. INDIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDONESIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. JAPAN POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. MALAYSIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. SINGAPORE POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. THAILAND POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. FRANCE POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. GERMANY POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. ITALY POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. QATAR POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. RUSSIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SPAIN POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. GLOBAL POINT OF CARE TESTING MARKET: SCORES
TABLE 47. GLOBAL POINT OF CARE TESTING MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL POINT OF CARE TESTING MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL POINT OF CARE TESTING MARKET: RANKING
TABLE 50. GLOBAL POINT OF CARE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL POINT OF CARE TESTING MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL POINT OF CARE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL POINT OF CARE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL POINT OF CARE TESTING MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL POINT OF CARE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL POINT OF CARE TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alere Inc
  • Ativa Medical Corporation
  • Becton, Dickinson, and Company
  • BIOMERIEUX SA
  • Chembio Diagnostics
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • Henry Schein, Inc
  • Informa PLC
  • Instrumentation Laboratory Company
  • Johnson and Johnson Service, Inc.
  • Medtronic plc
  • Polymer Technology Systems, Inc.
  • QIAGEN GmbH
  • Roche Holding AG
  • Siemens AG
  • Sienco, Inc.
  • WerfenLife, S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll